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ABSTRACT: The neuroblastoma SK-ER3 cell line obtained by
stable transfection of the human SK-N-BE cell line is proposed
as a model for the study of estrogen receptor activity in cells of
neural origin. In the SK-ER3 cell line the estrogen receptor,
once activated, initiates a differentiation program leading to
growth arrest, morphological changes, and acquisition of the
dopaminergic phenotype. In the absence of estrogens, this
program can be triggered by IGF-I, which can activate the
unliganded estrogen receptor via the ras-pathway. It is pro-
posed that this model system might recapitulate the events
occurring in vivo during the differentiation of the nervous sys-
tem and that IGF-I may play an important role in the activation
of estrogen receptor at the very early stage of brain develop-
ment affecting the differentiation of a number of hypothalamic
and extrahypothalamic brain regions. © 1997 Elsevier Sci-
ence Inc.
KEY WORDS: Neuroblastoma, Stable transfection, Estrogen re-
ceptor, Differentiation, Brain.
INTRODUCTION
Estradiol is a well-known differentiating agent covering a funda-
mental role in the development of reproductive and non reproduc-
tive tissues. In fact, it has been long known that the maturation of
chicken oviduct cells, mammalian uterine tissue, or frog hepato-
cytes is dependent upon estrogen priming [13]. On the basis of
these studies and as suggested by more recent work carried out on
ecdysone [19], another steroid endowed of differentiating potential
in insects, it could be postulated that estradiol starts the differen-
tiation of target, still multipotent blast cells, by inducing a series of
early genes, which in turn, would provoke a cascade of events
resulting in the activation of all the genes necessary for the final,
permanent, phenotype of the estrogen receptor-expressing cells
(e.g., for oviduct, differentiation is paralleled by the expression of
the progesterone receptor together with all the other proteins
typical of the mature cell like ovomucoid, ovalbumine, etc.).
The nervous system can be considered among the tissues target
for the estrogen differentiating activity. The current view of brain
sexual differentiation, in fact, suggests that, in the first few days of
life, the intracellular aromatization of the testosterone synthesized
by the gonads to 17b-estradiol (E2), which subsequently binds to
high-affinity estrogen receptors (ER), causes the acquisition of
those neural circuits, which in the adult animal will allow the
display of the male sexual behavior. In the absence of estrogens,
the adult animal will display a female-like behavior, independently
of the presence of the male sex chromosome in its genome
[2,5,15].
However, several localization studies prove that, during the
maturation of the nervous system, ERs are expressed in several
brain areas much earlier than expected on the basis of the theory
mentioned above. For instance in rat brain, ER appears in the basal
hypothalamus, preoptic area, amygdala, mid brain and spinal cord
on day E14. The number of ER-expressing cells increases in each
of these areas on days E15, E17, and P0 [6,11]. Also, cells of the
peripheral nervous system express ER, as reported by Sohrabji et
al. [17]. In some of the above-mentioned brain areas (e.g., the
hippocampus [12], the levels of ER increase during the late em-
bryonic phase to rapidly decrease at birth, that is, at the time in
which the estrogen-induced differentiation of neural cells should
occur. It is worth underlining that the current belief on the events
triggering brain sexual differentiation regards the embryonal ex-
pression of the ER as deprived of any functional meaning. In fact,
it is known that the maternal estradiol cannot activate the embryo
receptors due to the presence of a-fetoprotein, which ties up the
circulating hormone and prevents its binding to the ER. The
aromatizable testerone, on the other hand, is produced only peri-
natally. Nevertheless, studies carried out in cultures of dispersed
embryo neural cells demonstrate that estradiol may interact with
the expressed ER to influence the cell physiology and prove that
the ER, expressed in embryonal neural cells, are fully functional
[4,16,18]. On the basis of these findings it could be hypothesized
that ER might have an effect on the earlier phases of the nervous
system development. Further experiments should be undertaken to
prove this hypothesis. However, the use of cultures of dispersed
embryonal cells have a number of drawbacks limiting their use: the
majority of which is represented by the fact that only a minute
percentage of the neural cells expresses the ER.
The goal of our studies was to set up a cell system for the study
of ER activity in cells of neural origin.
METHODS
Neuroblastoma Cell Growth and Transfection
SK-N-BE and SK-ER3 cells were routinely cultured in RPMI-
1640 medium without phenol red (Sigma) and supplemented with
10% charcoal stripped fetal bovine serum (DCC-FBS). For trans-
fection studies, 24 h before transfection, 4 3 105 cells were plated
in six-well dishes containing 3 ml phenol red-free RPMI 1640
medium supplemented with 10% DCC-FBS. Six hours before
addition of the CaPO4/DNA mixture, the medium was replaced
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with DMEM containing 10% DCC-FBS. In a typical transient
transfection experiment, the cells were transfected with 200 ml of
a suspension containing 0.1 mg/ml of ERcDNA, 0.05 mg/ml of the
reporter gene (pVEREt-kCAT), 0.1 mg/ml of p21(asn17) ras, and
0.12 mg/ml of carrier DNA (pGEM3z) in 1.8 ml of medium (in the
stable transfection the reporter gene was omitted) [9]. Sixteen
hours after the addition of the precipitate, the medium was dis-
carded and, after a few washes with RPMI 1640, replaced with
phenol red-free RPMI 1640 containing 1% DCC-FBS. In transient
transfections, the pharmacological treatments were started at this
point. Twenty-four hours later the medium was removed, the cells
were washed several times with PBS, and cellular extracts were
prepared following the protocol of the CAT-ELISA kit (Boehr-
inger M., Milan, Italy). The protein content was measured by
Bradford’s assay. Each experiment was repeated at least four
times.
For stably transfected cells, the selection was done in the
presence of 300–400 mg of geneticine/ml. The surviving clones
were then amplified and analyzed for ER expression [9].
Cell Proliferation Studies
Cells (1.5 3 104) were plated in triplicate in 25-cm2 flasks. Cell
number and viability in the presence or absence of E2 (1 nM) was
evaluated using 0.4% trypan blue stain (Sigma) according to the
technical instructions.
3H Thymidine Incorporation Assay
3H-thymidine incorporation was estimated by plating 104 cells
in a six-well dish. The cells were grown for 12 days following the
hormonal treatment. 3H-thymidine (Amersham, 1.0 mCi/ml me-
dium) was added 3 h before harvesting the cells. Cells were lysed
and assayed for radioactivity by addition of scintillation fluid.
Morphometric Analysis
SK-ER3 cells were grown on coverslips pretreated with 5%
gelatin in the presence or absence of E2 (1 nM). Cells were then
fixed at room temperature with 4% paraformaldehyde in 200 mM
borate buffer for 10 min. After a few rinses the cells were incu-
bated for 5 min in the presence of 2% horse serum and 0.1% Triton
X-100 in PBS. Anti-Tau (ICN) and antisynaptophysin (Boehring-
er–Mannheim) at 1:100 and 1:5 dilutions, respectively, were ap-
plied and incubated overnight at 4°C in a humidified chamber.
After several rinses in PBS, cells were incubated with a 1:100
dilution of a fluorescein-conjugated horse antimouse secondary
antibody (Vector Laboratories) for 2 h at room temperature. After
FIG. 1. Left: contrast phase photograph of SK-N-BE and SK-ER3 cells 6 1 nM E2 for 10 days (3130; Nikon
microscope). Right: upper panel: cells were plated in duplicate and counted at the indicated day by trypan blue
exclusion in a Burker chamber. The data reported represent the avarage of three separate experiments. Lower
panel: SK-N-BE (open bars) and SK-ER3 (filled bars) cells were grown for 12 days, then fixed and analyzed as
reported in the methods section. Black bars refer to SK-ER3 cells treated with 1 nM estradiol for the entire lenght
of the experiment. Bars represent the SD of a minimum of 150 measurements/experimental group carried out on
cells grown in three separate experiments.
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several washes, coverslips were mounted onto slides using Perma-
Fluor (Helena Laboratories). Main neuritic length of individual
neurons was quantified using an automatic image analyzer
equipped with IMAGE software developed and generously pro-
vided by Wayne Rosband (National Institutes of Health, Bethesda,
MD). A total of 60 cells were analyzed for each experimental
group. Statistical analysis was performed using ANOVA. p # 0.05
was taken as the level of statistical significance.
RESULTS
Ligand-Operated Activation of ER Causes Growth Arrest and
Differentiation of SK-ER3 Neuroblastoma Cells
To set up a system for the study of the effects of estrogens on
neural cells we engineered a neuroblastoma cell line by stable
transfection of the ER cDNA under the control of a constitutive
promoter. As parental neuroblastoma we selected a cell line rep-
resenting an early stage of neural crest cell differentiation. Cells of
the human line SK-N-BE, in fact, have been reported to intercon-
vert between two cell phenotypes: neural and melanocytic, which
are known to represent the very initial stage of the differentiation
of neural crest cells. The theoretical limitation of the model we
chose is that neuroblastoma cells might express a number of genes
conferring them the tumoral, proliferative phenotype, which might
mask or override the expression of genes characterising a neural
cell; furthermore, in these cells the expression of the ER is due to
the addition of an heterologous gene that might not be subjected to
the natural regulatory mechanisms. On the other hand, we thought
that this model would have facilitated the identification of the
genes target of the ER receptor and would have been amenable to
a number of pharmacological and biochemical studies that ‘‘phys-
iological relevance’’ could then be evaluated either in vivo or in
primary culture cells.
In the cell line we generated and named SK-ER3, as shown in
Fig. 1, the activation of the ER results in morphological alterations
and growth arrest quantitated by measurement of the neurite length
and cell counting, respectively. Subsequent experiments by cell
counting (Table 1) and analysis of tritiated thymidine incorpora-
tion (not shown) demonstrated that the exposure to the hormone
must be prolonged for at least 16 h to commit the cells to the
proliferation arrest. After this time period, the hormone can be
removed from the medium without affecting the growth arrest
program. To induce the morphological changes, a very short
hormonal treatment (as short as 2 h) is sufficient [9]. It appears,
therefore, that, at least in these SK-ER3 cells, the estrogen-depen-
dent morphological differentiation program initiates independently
and at an earlier time than that one leading to proliferation block-
age. Interestingly, the morphological differentiation parallels the
appearance of a number of biochemical markers (e.g., synaptophy-
sin and Tau) [9] and the acquisition of the capability to synthesize,
store and release a specific neurotransmitter (dopamine) [1]. This
demonstrates that the estrogen-treated cells develop towards the
phenotype of a mature, postmitotic neuron. Because other studies
done in neural cells in culture or in vivo have demonstrated that
estrogen can indeed induce the synthesis of Tau and synaptophysin
and that there is a strong functional link between ER-expressing
FIG. 2. Effect of IGF-I treatment on SK-ER3 morphology and growth. SK-ER3 cell were treated with IGF-I (10 nM) solubilized in the
estrogen-deprived medium. IGF-I (10 nM) was added every 48 h time. After 6 days in culture, the cells were counted (left panel) and neurites measured
(right panel) as described in the methodology section. * p # 0.01 vs. control; ** p # 0.001 vs. control.
TABLE 1
SK-ER3 MUST BE TREATED WITH E2 FOR A MINIMUM TIME
LENGTH OF 16 HOURS TO STOP PROLIFERATION
E2 Treatment (Length) 3H Thymidine Incorporation (at the 12th Day in Culture)
Controls 4,700 6 140
10 min 2,200 6 260
30 min 1,900 6 220
1 h 1,600 6 50
4 h 1,900 6 110
16 h 0.02 6 5
12 days 0.02 6 6
Cells were treated with estrogens for the indicated time, then the medium
was removed and replaced with fresh medium deprived of steroids. Cells
were grown for 12 more days then the 3H thymidine incorporation assay
was performed in triplicate.
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and dopaminergic neurons, the effects observed in our model
system might recapitulate what occurs in neural cells in vivo. We,
therefore, postulated that also the proliferative and differentiating
effects reported for SK-ER3 could mimic what is occurring during
the development of the central nervous system.
Cross-talk Between ER and IGF-1R Leads to Differentiation of
SK-ER3 Cells
Figure 1 shows that, even if grown in the absence of estrogens,
SK-ER3 cells have a morphology that differs from the parental cell
line: in having a more elongated cell body, longer neurites and
having lost the tendency to grow in clusters, characteristic of the
SK-N-BE cells. In a series of studies aimed at understanding the
causes of this differentiated phenotype, we discovered that IGF-I
can substitute for estradiol in the activation of the ER [10]. In fact,
treatment of SK-ER3 cells with insulin or IGF-1 causes elongation
of the neurites and growth arrest (Fig. 2). The effect on growth is
of particular interest because IGF-1 has a proliferative activity in
the parental SK-N-BE cell line (data not shown).
To prove that the effect of IGF-1 is indeed carried out through
the ER, we performed a series of studies on the transcriptional
activation of ER using the cotransfection assay in which the ER
was transfected in SK-N-BE cells together with a reporter gene
constituted by a basal thymidine kinase promoter with the estrogen
responsive element driving the gene coding for chloramphenicol
acetyltranferase (CAT). In this assay we could prove that the
unliganded ER could be transcriptionally activated by treatment of
the cells with IGF-1 (not shown) or insulin at high concentration.
The extent of transcriptional activation of the ER induced by
insulin or IGF-1 was dependent on the concentration of these
FIG. 3. Activation of ER transcriptional activity by IGF-I. Cotransfection
assay in SK-N-BE cells. After calcium phosphate-mediated transfection of
the reporter gene and the expression plasmid containing ER, the cells were
treated as specified in the figure for 48 h, then killed for the preparation of
the extracts for the CAT quantitation. The concentrations of insulin utilized
were 0.1, 1, and 10 mM. NGF concentration was 10 mM. * p # 0.05 and
** p # 0.001 vs. control.
FIG. 4. Schematic view of the potential mechanisms regulating brain sexual differentiation. The current hypothesis of estrogen-dependent
brain sexual differentiation depicted in the left panel might be revised in light of the potential activation of unliganded ERs by growth factors.
ER activated by hormones binding to membrane receptors might have a role in the maturation of selected neurons in the earliest stages of
brain development.
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hormones in the medium. Moreover, we demonstrated that this
effect was linked to the activation of a specific signal transduction
pathway requiring the presence of activated ras [14]. This was
proved by the use of a dominant negative mutant of ras (the p21
Asn17). As shown in Fig. 3, the presence of p21 (Asn17) com-
pletely blocked the insulin-dependent activation of ER. Interest-
ingly, NGF at a concentration as high as 10 mM did not influence
the ER capability to induce CAT transcription. This effect ap-
peared to be specific for IGF-1 because treatment of these cells
with NGF did not result in ER activation (Fig. 3).
DISCUSSION
The model system SK-ER3 appears to represent an interesting
tool for the study of estrogen-mediated differentiation of neural
cells. Other authors have utilized stable transfection for the con-
struction of cells of neural origin expressing the ER [8]. Interest-
ingly, the cell system generated by those authors does not display
the breadth of response to estrogens shown with SK-ER3 cells. We
believe that the reason for this resides in the choice of the parental
cell line: Lusting et al. [8], in fact, transfected with ER the PC12
cell line, which is a phaeochromocytoma instead of a neuroblas-
toma cell line [8]. It is therefore likely that the phaeochromocy-
toma cells have reached a stage of differentiation in which certain
genes cannot be activated by estrogens anymore and, therefore, the
E2 differentiating potential cannot be fully expressed.
The findings here reported with regard to the effect of estrogens
on SK-ER3 cells might prompt us to reconsider the current hy-
pothesis on the activity of this sex hormone and its cognate
receptor in the developing nervous system. If IGF-1 indeed acti-
vates the unliganded estrogen receptor in vivo, we may hypothe-
size that this growth factor, synthesized at relatively high concen-
tration by the developing brain, induces the terminal differentiation
of a subset of neuroblast expressing the ER in brain areas (and in
the peripheral nervous system) that are not commonly considered
as sexually dimorphic (e.g., hippocampus). It remains to be estab-
lished whether this effect mediated by IGF-I is important for the
development of neurons that might be endowed of sex-specific
activity or not. On this line of thoughts a study on the expression
of IGF-I and its cognate receptor in relation to the embryo sex is
quite interesting. Male mice carrying null mutations of the genes
encoding IGF-I/IGF-I-R do not display mating behavior [3,7].
However, it should be underlined that this deficiency could be due
to the low levels of serum testosterone of these mice. The finding
that multiple signals can activate the ER compels us to revise the
view of the role of this receptor in the development of the CNS that
might be far less schematic than previously thought (Fig. 4).. We,
therefore, propose that unliganded ER can be activated by IGF-1 or
insulin very early during the differentiation of the nervous system
to direct the differentiation of neural cells precursors; on the basis
of this hypothesis we believe that the brain areas where differen-
tiation is controlled by ER are much more numerous than previ-
ously believed and are certainly not restricted to those areas that
are involved in the control of sex-related functions.
We are well aware of the fact that the crosscoupling between
ER and IGF 1R described in the present study could be linked to
the specific model system utilized, and more investigations are
required to prove that such a functional coupling also occurs in the
developing neural cells. Yet the SK-ER3 models system might
represent a unique tool for the initial dissection of the molecular
events triggered in response to estrogens in cell of neural origin.
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